Cargando…

Serum CXCL5 Detects Early Hepatocellular Carcinoma and Indicates Tumor Progression

Chemokines or chemotactic cytokines play a pivotal role in the immune pathogenesis of liver cirrhosis and hepatocellular carcinoma (HCC). Nevertheless, comprehensive cytokine profiling data across different etiologies of liver diseases are lacking. Chemokines might serve as diagnostic and prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laschtowitz, Alena, Lambrecht, Joeri, Puengel, Tobias, Tacke, Frank, Mohr, Raphael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049661/ https://www.ncbi.nlm.nih.gov/pubmed/36982370 http://dx.doi.org/10.3390/ijms24065295

Ejemplares similares

Preoperative Immunotherapy in Hepatocellular Carcinoma: Current State of the Art
por: Laschtowitz, Alena, et al.
Publicado: (2023)

The APAC Score: A Novel and Highly Performant Serological Tool for Early Diagnosis of Hepatocellular Carcinoma in Patients with Liver Cirrhosis
por: Lambrecht, Joeri, et al.
Publicado: (2021)

Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma
por: Mohr, Raphael, et al.
Publicado: (2021)

Acetyl-CoA Carboxylase Inhibition as a Therapeutic Tool in the Battle Against NASH: Hitting More Than Just One Mechanism?
por: Lambrecht, Joeri, et al.
Publicado: (2020)

Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease
por: Lambrecht, Joeri, et al.
Publicado: (2021)

Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors
por: Hellberg, Teresa, et al.
Publicado: (2020)

Monocyte dysregulation: consequences for hepatic infections
por: Sellau, Julie, et al.
Publicado: (2021)

Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease
por: Puengel, Tobias, et al.
Publicado: (2022)

In Situ Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma
por: Lurje, Isabella, et al.
Publicado: (2021)

Association of Serum Calprotectin Concentrations with Mortality in Critically Ill and Septic Patients
por: Wirtz, Theresa H., et al.
Publicado: (2020)

Atezolizumab and bevacizumab-induced encephalitis in advanced hepatocellular carcinoma: Case report and literature review
por: Özdirik, Burcin, et al.
Publicado: (2021)

Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury
por: Puengel, Tobias, et al.
Publicado: (2017)

From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis
por: Mohr, Raphael, et al.
Publicado: (2021)

The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors
por: Geisler, Lukas, et al.
Publicado: (2021)

Pathogen detection in RNA-seq data with Pathonoia
por: Liebhoff, Anna-Maria, et al.
Publicado: (2023)

Inflammatory Cytokines Associated with Diagnosis, Tumor Grade and Prognosis in Patients with Neuroendocrine Tumors
por: Geisler, Lukas, et al.
Publicado: (2022)

Studying metabolism with multi-organ chips: new tools for disease modelling, pharmacokinetics and pharmacodynamics
por: Shroff, Tanvi, et al.
Publicado: (2022)

Serum CXCL5 level is associated with tumor progression in penile cancer
por: Mo, Miao, et al.
Publicado: (2021)

The Diagnostic Approach towards Combined Hepatocellular-Cholangiocarcinoma—State of the Art and Future Perspectives
por: Eschrich, Johannes, et al.
Publicado: (2023)

CXCL8, CXCL9, and CXCL10 serum levels increase in syphilitic patients with seroresistance
por: Dong, Xiaoyan, et al.
Publicado: (2021)

Serum CXCL9 Levels Are Associated with Tumor Progression and Treatment Outcome in Patients with Nasopharyngeal Carcinoma
por: Hsin, Li-Jen, et al.
Publicado: (2013)

Assessment of serum CXCL9 and pentraxin 3 as novel markers for hepatocellular carcinoma in cirrhotic hepatitis C patients
por: Mehanna, Rafik Gabbour, et al.
Publicado: (2023)

Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing Cholangitis
por: Özdirik, Burcin, et al.
Publicado: (2022)

Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma
por: Peiseler, Moritz, et al.
Publicado: (2021)

Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC
por: Loosen, Sven H., et al.
Publicado: (2021)

The Serum Levels of the Soluble Factors sCD40L and CXCL1 Are Not Indicative of Endometriosis
por: Pateisky, Petra, et al.
Publicado: (2016)

Serum CXCL13 Level is Associated with Tumor Progression and Unfavorable Prognosis in Penile Cancer
por: Mo, Miao, et al.
Publicado: (2020)

Pulmonary Complications in Patients with Liver Cirrhosis
por: Benz, Fabian, et al.
Publicado: (2020)

Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2016)

Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis
por: Loosen, Sven H, et al.
Publicado: (2021)

Serum TGF-β1: A Potential Biomarker for Early Detection of Hepatocellular Carcinoma
por: He, Jian, et al.
Publicado: (2016)

Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast
por: Kim, Milim, et al.
Publicado: (2021)

Serum Autoantibody Measurement for the Detection of Hepatocellular Carcinoma
por: Middleton, Catrin H., et al.
Publicado: (2014)

The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression
por: Yin, Xiaowan, et al.
Publicado: (2019)

Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma
por: Cao, Zhongwei, et al.
Publicado: (2014)

Overexpression of CXCL2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma
por: Ding, Jun, et al.
Publicado: (2018)

Chemokine CXCL10 Modulates the Tumor Microenvironment of Fibrosis-Associated Hepatocellular Carcinoma
por: Brandt, Elisa F., et al.
Publicado: (2022)

Low Serum Levels of Soluble Receptor Activator of Nuclear Factor κ B Ligand (sRANKL) Are Associated with Metabolic Dysregulation and Predict Long-Term Mortality in Critically Ill Patients
por: Puengel, Tobias, et al.
Publicado: (2021)

CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple Sclerosis
por: Marastoni, Damiano, et al.
Publicado: (2021)

CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic ‘window of opportunity’
por: Greisen, Stinne Ravn, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pi74pa18al77avhfv0i27aghjd